Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04215029 · ClinicalTrials.gov registry record · NA
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
A NA study of Stage III Prostate Cancer AJCC v8 and Cancer Survivor, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT04215029 is a NA study of Stage III Prostate Cancer AJCC v8 and Cancer Survivor that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 6 participants, below the 249-participant average among 28 other Stage III Prostate Cancer AJCC v8 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04215029, a NA study of Stage III Prostate Cancer AJCC v8 and Cancer Survivor, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well a lifestyle intervention works in reducing prostate cancer disparities among African American prostate cancer patients and their spouses or romantic partners. A lifestyle intervention may help researchers learn if social support can help African American prostate cancer patients and their partners improve their quality of life, support from their partner, physical activity, diet, and inflammation.
Conditions Studied
Interventions
- OTHER Interview
- BEHAVIORAL Exercise Intervention
- OTHER Informational Intervention
- OTHER Nutritional Assessment
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-08-27 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04215029
The ClinicalTrials.gov registry entry for NCT04215029 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 249-participant average among 28 other Stage III Prostate Cancer AJCC v8 trials with a reported enrollment target (98% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Stage III Prostate Cancer AJCC v8 appearing as the primary indexed condition, and to 4 interventions - of which Interview is the first listed.
NCT04215029 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04215029 about?
NCT04215029 is a clinical study titled "Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans". This trial studies how well a lifestyle intervention works in reducing prostate cancer disparities among African American prostate cancer patients and their spouses or romantic partners. A lifestyle intervention may help researchers learn if social support can help African American prostate cancer p...
What is the current status of trial NCT04215029?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2019-08-27. Estimated completion is 2026-07-31.
What conditions does trial NCT04215029 study?
This clinical trial studies the following conditions: Stage III Prostate Cancer AJCC v8, Cancer Survivor, Stage II Prostate Cancer AJCC v8, Stage I Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8.
What interventions are being tested in trial NCT04215029?
The interventions under investigation include: Interview (OTHER), Exercise Intervention (BEHAVIORAL), Informational Intervention (OTHER), Nutritional Assessment (OTHER).
Who is sponsoring clinical trial NCT04215029?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04215029 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage III Prostate Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
RECRUITING · NA
-
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
RECRUITING · NA
-
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
RECRUITING · NA
-
Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial
RECRUITING · NA
-
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
RECRUITING · NA
-
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.